Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-05FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Labetalol Hydrochloride from Hospira, Inc., signaling regulatory approval of an additional or re…
-
CLINICAL_TRIALS research · 2012-09-05Clinical Trial Update: Reducing Clinical Inertia in Diabetes Care [NA]
This is a completed clinical trial update from HealthPartners Institute about reducing clinical inertia in diabetes care, with related condi…
-
FDA approval · 2012-09-05FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves a generic fixed-dose combination of amlodipine and benazepril hydrochloride for hypertension (ANDA 202239) by Rising Pharma Hol…
-
FDA approval · 2012-09-04FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for labetalol hydrochloride (Hospira, Inc.), supporting the generic drug's availability.
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Valsartan Intensified Primary Care Reduction of Blood Pressure Study [Phase 4]
Phase 4 trial update evaluating valsartan to intensify primary care for blood pressure reduction; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2012-08-28EMA Withdrawn: Sprimeo HCT (aliskiren;hydrochlorothiazide) — Novartis Europharm Ltd.
The EMA withdrew Sprimeo HCT (aliskiren and hydrochlorothiazide) from the market.
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Effects of Black Soy Peptide Supplementation on Blood Pressure [Phase 3]
A Phase 3 clinical trial evaluating black soy peptide supplementation for lowering blood pressure in hypertension has completed.
-
FDA approval · 2012-08-24FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Civica, Inc.)
The FDA approved a supplemental application for labetalol hydrochloride submitted by Civica, Inc. The snippet does not detail the specific c…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Telmisartan+Amlodipine Fixed Dose Combination in Hypertension [Phase 3]
Phase 3 trial results for a fixed-dose combination of telmisartan and amlodipine in hypertension have been completed, with results posted.
-
FDA approval · 2012-08-24FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental abbreviated new drug application for diltiazem hydrochloride from Sun Pharmaceutical, a generic calcium channel …
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of fimasartan in mild to moderate essential hypertension has completed.
-
CLINICAL_TRIALS research · 2012-08-22Clinical Trial Update: The Effect of Angiotensin II Type 1 Receptor Antagonists on the Size and Expansion Rate of Abdominal Aortas in Hypertensive Patients
A clinical trial update examining whether angiotensin II type 1 receptor antagonists affect the size and growth rate of abdominal aortic ane…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients
This document reports the completion and posting of results from a trial evaluating telmisartan's effect on blood pressure and cardiovascula…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients [Phase 4]
A Phase 4 randomized trial investigated losartan effects on endothelial dysfunction and insulin resistance in obese patients; results posted…
-
CLINICAL_TRIALS research · 2012-08-16Clinical Trial Update: Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression [NA]
A completed study update examining the pathophysiological mechanisms of hypertensive left ventricular hypertrophy and strategies to optimize…
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Comparison of Catheterized and Clean Catch Urine Specimens for Protein/Creatinine Ratio in Preeclampsia Evaluation
This completed trial compared catheterized versus clean-catch urine specimens for measuring the protein/creatinine ratio in evaluating preec…
-
FDA approval · 2012-08-15FDA Approved: METOPROLOL SUCCINATE — Original Application (BluePoint Laboratories)
FDA approved a generic metoprolol succinate product (BluePoint Laboratories) via an Original Application (ANDA). The product is a generic be…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Evaluation of Integrating Self Blood Pressure Monitoring Into Urban Primary Care Practices [NA]
A completed clinical trial evaluating the integration of self blood pressure monitoring into urban primary care practices.
-
FDA approval · 2012-08-13FDA Approved: ZESTRIL — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Zestril (lisinopril) submitted by Upsher-Smith Laboratories.
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: Clinical Study of Wrist Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 Standard [NA]
Completed clinical trial evaluating the efficacy/accuracy of wrist blood pressure measurements in conformance with the ANSI/AAMI SP10 standa…
-
FDA label_change · 2012-08-13FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)
FDA supplemental approval for ZESTORETIC (lisinopril and hydrochlorothiazide) submitted by Almatica Pharma Inc. to update the product label.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Additive Effects of Pravastatin and Valsartan [Phase 4]
Phase 4 clinical trial evaluating the additive effects of pravastatin and valsartan in patients with hypertension and high cholesterol.
-
FDA approval · 2012-08-09FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods' original ANDA for a losartan potassium and hydrochlorothiazide combination tablet.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension. [Phase 4]
Phase 4 trial completed evaluating candesartan for lowering blood pressure in obese, insulin-resistant patients with hypertension.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria [Phase 2]
A Phase 2 trial comparing INV-144 with Losartan in patients with hypertension and type 2 diabetes mellitus and macroalbuminuria has complete…